Posttransplant cyclophosphamide vs cyclosporin A and methotrexate as GVHD prophylaxis in matched sibling transplantation

Posttransplant cyclophosphamide (PTCy) effectively prevents graft-versus-host disease (GVHD) after HLA-haploidentical hematopoietic stem cell transplantation (HSCT). The use of PTCy in HLA-identical HSCT is less explored. We conducted a retrospective study of 107 consecutive patients undergoing an H...

詳細記述

保存先:
書誌詳細
出版年:Blood Adv
主要な著者: Kwon, Mi, Bailén, Rebeca, Pascual-Cascón, María Jesús, Gallardo-Morillo, Ana Isabel, García Sola, Abel, Balsalobre, Pascual, Solán, Laura, Dorado, Nieves, Muñoz, Cristina, Serrano, David, Martínez-Laperche, Carolina, Buño, Ismael, Anguita, Javier, Díez-Martin, José Luis
フォーマット: Artigo
言語:Inglês
出版事項: American Society of Hematology 2019
主題:
Clinical Trials and Observations
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6855126/
https://ncbi.nlm.nih.gov/pubmed/31698447
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2019000236
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料